This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Digital Pathology Market

Market Insights on Digital Pathology covering sales outlook, demand forecast & up-to-date key trends

Digital Pathology Market by Product Type (Equipment, Software, Services), Application (Clinical Pathology, Molecular Diagnostics, Basic & Applied Research, Drug Development) End User & Region - Forecast to 2021 - 2031

Digital Pathology Market Snapshot

[178 Pages Report] The global Digital Pathology Market value is expected to total US$ 6,199 Mn for 2021, according to Future Market Insights. The overall sales of digital pathology products and services are expected to reach US$ 22,870.2 Mn by 2031, growing at a CAGR of 13.5% in the forecast 2021 – 2031.

Innovations in technology and integration of new services such as electronic medical records in the global healthcare sector are driving interest towards digital pathology solutions. While on premise information systems use will remain dominant at US$ 626.8 Mn, cloud-based information systems are likely to rise at a 16.9% CAGR through 2031. 

Customize this Report

Let us know your requirement to get
100% FREE customization

Key Points Covered in Digital Pathology Market Study

  • Market estimates and forecast 2016-2031
  • Key drivers and restraints impacting Digital Pathology Market growth
  • Segment-wise analysis, Country-wise, and Region-wise Analysis
  • Competition Mapping and Benchmarking
  • Key Product Innovations and Regulatory Climate
  • COVID-19 Impact on Digital Pathology and How to Navigate
  • Recommendation on Key Winning Strategies 

2016-2020 Digital Pathology Market Outlook Compared to 2021-2021 Forecast

According to Future Market Insights (FMI), the sales of Digital Pathology products and services have grown at ~10% CAGR from 2016-2020. Increasing adaptation of digital pathology devices in emerging economies to improve healthcare services is elevating growth.

The global Digital Pathology Market was valued at~ US$ 5.54 Bn in 2020. The market is expected to grow at a CAGR of ~ 13.5% during the forecast period of 2021-2031. Elevated healthcare-based IT spending and increased focus on cancer research are expected to fuel the growth of digital pathology devices across the globe over the forecast period.

Digital Pathology Market Download Report Brochure

Manufacturers are focusing on the integration of digital pathology with cloud platforms, and are collaborating with the cloud service providers for data sharing and scanning services to clients. Consumers are focusing on health issues and are proactively conducting full-body check-ups, which tends to the growth of the digital pathology market in the forecast period.

How are Research and Development Initiatives Contributing towards Digital Pathology Market Growth?

Recent years have witnessed increased investments for biosimilar research and developments programs, especially for cancer treatment and Covid-19 treatment which has significantly driven the growth of the digital pathology industry. Pharmaceutical companies are allocating tasks of biosimilar development to Contract Research Organizations (CROs), in-vitro diagnostics (IVD) laboratories, clinical laboratories, and regulatory consultants.

These companies are improvising to provide more cost-effective solutions to clients, creating a requirement for digital pathology devices to diagnose, research, and invent for effective healthcare solutions.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

How is the Demand for Cancer Diagnostic Research Influencing Development Activities?

The widespread prevalence of cancer is resulting in the increased spending on digital pathology devices. Complications that are arising due to late diagnosis of cancer, especially in the case of blood cancer and lung cancer, are resulting in the need for large capital resources during treatments and diagnosis.

The success of digital pathology in research is driving the demand for these systems from the cancer research sector. This is also attracting government investors to invest in digital pathology systems for clinical diagnostics applications.

According to the National Health Society (NHS), In 2018, the U.K., cancer services donated around US$ 8.3 Bn to the NHS. A major amount is spent on diagnosis and monitoring of cancer treatment. This defines the high demand for digital pathology systems in cancer diagnostic and monitoring processes.

What are the Factors Restraining Demand for Digital Pathology Products?

The higher cost of digital pathology services is the major factor hampering the growth of the market in most low-income countries. The cost of maintenance and training for digital pathology is very high and may not be suitable for small-scale laboratories.

Lack of standardization in regulatory guidance in the commercial sale of digital pathology products hampers growth prospects. In the U.S, guidelines specifically indicate that digital pathology services are to be used only in research and development activities and not for clinical use. Such regulations and guidelines limit the adoption of digital pathology products and slow-down market growth significantly.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

What is the Impact of the COVID-19 Crisis on Market Developments?

The impact of the covid-19 pandemic on the market has largely been positive. The introduction of rapid test kits for the covid-19 virus has strongly aided sales. However, restrictions in terms of transportation, production, and technological developments are short term concerns. Investments in healthcare research are expected to continue rising for the foreseeable future, creating lucrative opportunities, especially with major developments in AI and analytics improvements through the coming decade.

Country-wise Insights

How is the Digital Pathology Market Faring in the U.S.?

The U.S. holds a 36% share in the global market. The presence of established players in the region, rising adaptation of digital imaging methods and adoption of advanced technology provides key opportunities for manufacturers to deliver novel products. The research and development sector in the U.S. is highly developed.

Increased use of digital pathology devices for diagnosis is coupled with favorable reimbursement policies in the U.S., which improves the quality of cancer diagnosis, is further fueling growth in the country.

What are the Factors Driving Revenue Generation in Germany?

The German market accounts for over 20% of the Europe market in 2021. The country has strict guidelines which are proposed by the Association of German Pathologists. This is key for operational use to IT experts, pathologists and researchers.

Scientists in pathology laboratories will accelerate the demand for pathology services in in the EU, with Germany holding a prime position owing to a matured healthcare sector. The prevalence of cancer and chronic conditions supports regional growth.

What are the Key Factors Which Enabling Growth in China?

The market for digital pathology in China is exhibiting a 23.5% CAGR and is expected to account for more than 70% of the East Asia market in 2031. China is the leading supplier of rapid diagnostic kits on a global scale due to the easy availability of the manpower and raw material.

China played a major role in supplying covid-19 diagnostic kits all over the globe. The availability of funding by the government for public healthcare and access to resources are major factors for the growth of the market. 

What is the Scope of Growth for the Market in India?

India is a high potential market for digital pathology services, which is expected to hold 70.0% of the South Asia value share in 2031 at a CAGR of nearly 26% during the forecast period. The growth can be largely attributed to the availability of low-cost labor.

An increase in demand for novel treatment options, better facilities for patient care, and reduction in expenses in laboratory facilities is expected to fuel growth. The Indian government is now focusing on increasing investments into the healthcare sector through the “Make in India” initiative.

The government is also raising funds for the research and development in the healthcare sector every year to develop new drugs and medical devices which supports the rise in regional revenue. In July 2021, the Union government announced a plan to set up over 42 diagnostic and virology research laboratories in the country at a cost of Rs. 324 crores.

Category-wise Insights

Why are Clinical Pathology Applications Highly Sought-after?

Clinical laboratories primarily diagnose the cause of the disease by the means of body fluids analysis including blood tests, urine tests, or tissue extracts through digital pathology devices. Clinical pathology applications will account for 30% of the global value share in 2021.

 The increasing prevalence of the chronic diseases, cancer patients, diabetes cases, and more are necessary. Consequently, the demand from clinical pathology laboratories will continue to rise for the foreseeable future.

How are Hospitals Contributing to Market Growth?

Until recently, hospitals would outsource diagnostics of samples to external centers to analyze body fluids in a bid to minimize costs. However, through the coming decade, hospitals are expected to raise funds and develop their own diagnostic laboratories to provide services for customers inside one roof.

The need pathology devices with developed technologies significantly boosts the demand and creates revenue generation opportunities through the upcoming decade. The segment will account for 34.5% of the market in 2021.

Competitive Landscape

Manufacturers are focusing on product development by offering a wide range of diagnostic products. Moreover, major players in the digital pathology market are focused on enhancing their global and regional presence through acquisitions and expansion on a global scale.

  • In May 2021, Leica Biosystems collaborated with the European Society for Digital and Integrative Pathology (ESDIP) to Support the pathology Labs to develop the laboratories according to new digital pathology devices.
  • In March 2021, Roche signed a definitive merger agreement with GenMark Diagnostics, Inc. in an effort to widen its portfolio and distribution channel for consumers in Europe.

Scope of the Report

Attributes

Details

Base year considered

2020

Historical data available for

2016 – 2020

Forecast period

2021 – 2031

Forecast units

Value (US$) Mn and Volume (Units)

Key Segments covered

Product Type, Application, End-User, and Region

Key countries covered

US, Canada, Brazil, Mexico, Germany, U.K., France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia and New Zealand, GCC Countries, Turkey, South Africa

Key Players

  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Huron Technologies International Inc.
  • Koninklijke Philips N.V.
  • Olympus Corporation
  • Hamamatsu Photonics K.K.
  • Carl Zeiss AG
  • Nikon Corporation
  • 3DHISTECH Ltd.
  • Hologic Inc.
  • PerkinElmer, Inc.
  • Visiopharm
  • OptraSCAN, Inc.
  • Inspirata, Inc.
  • Sectra AB.

Report coverage

Revenue forecast, volume analysis, pricing analysis, company share, competitive landscape, growth factors, and trends

Customization & Pricing

Available upon Request

key segment

By Product Type:

  • Equipment
    • Whole Slide Scanners
      • Brightfield Slide Scanners
      • Fluorescence Slide Scanners
      • Combination Slide Scanners
    • Clinical Microscope
    • Tissue Microarrays
  • Softwares
    • Image Viewing and Analysis Softwares
      • On-premise
      • Cloud-based
    • Digital Pathology Information Systems
      • On-premise
      • Cloud-based
  • Services
    • Installation and Integration Services
    • Consulting Services
    • Maintenance and Validation Services

By Application:

  • Clinical Patholog
  • Molecular Diagnostics
  • Basic & Applied Research
  • Drug Development
  • Others

End-User:

  • Hospitals
  • Diagnostic Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Forensic Laboratories
  • Research Institutes
  • Contract Research Organizations (CROs)
  • Clinics

Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia & Pacific
  • The Middle East and Africa (MEA)

Frequently Asked Questions

The global digital pathology market is worth USD 6.19 Bn in the year 2021 and is expected to reach USD 22.87 Bn by 2031 owing to extensive research toward the development of new techniques for patient treatment.

The demand for digital pathology kits will increase in the forecast period as the biotech companies are increasing research on cancer therapy kits to expand the product portfolio fulfilling the demands of the market rising at a CAGR of 13.5%.

Historically, the market has grown at a CAGR of 9.9% from 2016 to 2020.

Integration of healthcare IT systems and digital pathology technologies provides a combined system for healthcare services, which will create key opportunities for market players.

Growing demand for diagnostic laboratories has increased sales in the digital pathology market. Ongoing research on cancer diagnostics therapy will drive the market during the forecast years.

The cumulative market share of the top 5 players including Danaher Corporation, F. Hoffmann-La Roche AG, Huron Technologies International, Inc., Koninklijke Philips N.V., and Olympus Corporation constitutes around 71% of the overall market.

The U.S, Japan, China, Germany, and India are the top 5 countries that are driving the demand for the digital pathology market.

North America holds around 42.3% revenue share in the overall digital pathology market. The U.S. remains the fastest-growing country over Canada exhibiting a CAGR of 9.7% over the forecast period.

Europe is set to exhibit a CAGR of 10.3% during the forecast period owing to the high prevalence of cancer cases in the region.

The key exporters of digital pathology kits are countries such as the U.S., Japan, China, Germany, and India.

Japan’s digital pathology market remains the fastest growing market in developed nations. It is expected to exhibit a growth of 12.3% during the forecast period. South Korea holds a revenue share of 1.7% in the global digital pathology market.

Table of Content

   1. Executive Summary

    1.1. Global Market Outlook

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Product Innovation / Development Trends

4. Market Background

    4.1. Macro-Economic Factors

        4.1.1. Global GDP Growth Outlook

        4.1.2. Global Healthcare Outlook

        4.1.3. Per Capita Healthcare Expenditure Outlook

    4.2. Forecast Factors - Relevance & Impact

        4.2.1. Prevalence of Cancer & Chronic Diseases

        4.2.2. New Product Launches

        4.2.3. Increasing Number of Diagnostic Laboratories

        4.2.4. Funding for the Research Activities

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunity Analysis

5. COVID19 Crisis Analysis

    5.1. Current COVID19 Probable Future Impact

    5.2. Current GDP Projection and Probable Impact

    5.3. Current Economic Projection as compared to 2008 Economic analysis

    5.4. COVID19 and Impact Analysis

            5.4.1.1. Revenue By Product Type

            5.4.1.2. Revenue By Application

            5.4.1.3. Revenue By Modality

            5.4.1.4. Revenue By End User

            5.4.1.5. Revenue By Country

    5.5. 2020 Market Scenario

    5.6. Recovery Scenario – Short term, Midterm and Long Term Impact

6. Global Digital Pathology Devices Market Volume Analysis 2016-2020 and Forecast, 2021-2031

    6.1. Historical Market Volume (Units) Analysis, 2016-2020

    6.2. Current and Future Market Volume (Units) Projections, 2021-2031

        6.2.1.  Y-o-Y Growth Trend Analysis

7. Global Digital Pathology Devices Market - Pricing Analysis

    7.1. Pricing Analysis By Product Type

    7.2. Pricing Break-up

        7.2.1. Manufacturer Level Pricing

        7.2.2. Distributor Level Pricing

    7.3. Global Average Pricing Analysis Benchmark

8. Global Digital Pathology Market Demand (in Value or Size in US$ Mn) Analysis 2016-2020 and Forecast, 2021-2031

    8.1. Historical Market Value (US$ Mn) Analysis, 2016-2020

    8.2. Current and Future Market Value (US$ Mn) Projections, 2021-2031

        8.2.1. Y-o-Y Growth Trend Analysis

        8.2.2. Absolute $ Opportunity Analysis

9. Global Digital Pathology Market Analysis 2016-2020 and Forecast 2021-2031, By Product Type

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2016–2020

    9.3. Current and Future Market Size (US$ Mn) Trend Analysis and Forecast By Product Type, 2021-2031

        9.3.1. Equipments

            9.3.1.1. Whole Slide Scanners

                9.3.1.1.1. Brightfield Slide Scanners

                9.3.1.1.2. Fluorescence Slide Scanners

                9.3.1.1.3. Combination Slide Scanners

            9.3.1.2. Clinical Microscope

            9.3.1.3. Tissue Microarrays

        9.3.2. Softwares

            9.3.2.1. Image Viewing and Analysis Softwares

                9.3.2.1.1. On-premise

                9.3.2.1.2. Cloud-based

            9.3.2.2. Digital Pathology Information Systems

                9.3.2.2.1. On-premise

                9.3.2.2.2. Cloud-based

        9.3.3. Services

            9.3.3.1. Installation and Integration Services

            9.3.3.2. Consulting Services

            9.3.3.3. Maintenance and Validation Services

    9.4. Market Attractiveness Analysis By Product Type

10. Global Digital Pathology Market Analysis 2016-2020 and Forecast 2021-2031, By Application

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) Trend Analysis By Application, 2016–2020

    10.3. Current and Future Market Size (US$ Mn) Trend Analysis and Forecast By Application, 2021-2031

        10.3.1. Clinical Pathology

        10.3.2. Molecular Diagnostics

        10.3.3. Basic & Applied Research

        10.3.4. Drug Development

        10.3.5. Others

    10.4. Market Attractiveness Analysis By Application

11. Global Digital Pathology Market Analysis 2016-2020 and Forecast 2021-2031, by End User

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn) Trend Analysis By End User, 2016–2020

    11.3. Current and Future Market Size (US$ Mn) Trend Analysis and Forecast By End User, 2021-2031

        11.3.1. Hospitals

        11.3.2. Diagnostic Laboratories

        11.3.3. Pharmaceutical & Biotechnology Companies

        11.3.4. Forensic Laboratories

        11.3.5. Research Institutes

        11.3.6. Contract Research Organizations (CROs)

        11.3.7. Clinics

    11.4. Market Attractiveness Analysis By End User

12. Global Digital Pathology Market Analysis 2016-2020 and Forecast 2021-2031, by Region

    12.1. Introduction / Key Findings

    12.2. Historical Market Size (US$ Mn) Analysis By Region, 2016–2020

    12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2021-2031

        12.3.1. North America

        12.3.2. Latin America

        12.3.3. Europe

        12.3.4. South Asia

        12.3.5. East Asia

        12.3.6. Oceania

        12.3.7. Middle East & Africa

    12.4. Market Attractiveness Analysis By Region

13. North America Digital Pathology Market Analysis 2016-2020 and Forecast 2021-2031

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2020

    13.3. Current and Future Market Size (US$ Mn) Trend Analysis and Forecast By Market Taxonomy, 2021-2031

        13.3.1.  By Country

            13.3.1.1. U.S.

            13.3.1.2. Canada

        13.3.2. By Product Type

        13.3.3. By Application

        13.3.4. By End User 

    13.4. Market Attractiveness Analysis

    13.5. Key Market Participants - Intensity Mapping

    13.6. Drivers and Restraints - Impact Analysis

14. Latin America Digital Pathology Market Analysis 2016-2020 and Forecast 2021-2031

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2020

    14.3. Current and Future Market Size (US$ Mn) Trend Analysis and Forecast By Market Taxonomy, 2021-2031

        14.3.1.  By Country

            14.3.1.1. Brazil

            14.3.1.2. Mexico

            14.3.1.3. Argentina

            14.3.1.4. Rest of Latin America

        14.3.2. By Product Type

        14.3.3. By Application

        14.3.4. By End User 

    14.4. Market Attractiveness Analysis

    14.5. Key Market Participants - Intensity Mapping

    14.6. Drivers and Restraints - Impact Analysis

15. Europe Digital Pathology Market Analysis 2016-2020 and Forecast 2021-2031

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2020

    15.3. Current and Future Market Size (US$ Mn) Trend Analysis and Forecast By Market Taxonomy, 2021-2031

        15.3.1.  By Country

            15.3.1.1. U.K.

            15.3.1.2. Germany

            15.3.1.3. France

            15.3.1.4. Italy

            15.3.1.5. Spain

            15.3.1.6. Russia

            15.3.1.7. Rest of Europe

        15.3.2. By Product Type

        15.3.3. By Application

        15.3.4. By End User 

    15.4. Market Attractiveness Analysis

    15.5. Key Market Participants - Intensity Mapping

    15.6. Drivers and Restraints - Impact Analysis

16. East Asia Digital Pathology Market Analysis 2016-2020 and Forecast 2021-2031

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2020

    16.3. Current and Future Market Size (US$ Mn) Trend Analysis and Forecast By Market Taxonomy, 2021-2031

        16.3.1.  By Country

            16.3.1.1. China

            16.3.1.2. Japan

            16.3.1.3. South Korea

        16.3.2. By Product Type

        16.3.3. By Application

        16.3.4. By Modality

        16.3.5. By End User 

    16.4. Market Attractiveness Analysis

    16.5. Key Market Participants - Intensity Mapping

    16.6. Drivers and Restraints - Impact Analysis

17. South Asia Digital Pathology Market Analysis 2016-2020 and Forecast 2021-2031

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2020

    17.3. Current and Future Market Size (US$ Mn) Trend Analysis and Forecast By Market Taxonomy, 2021-2031

        17.3.1.  By Country

            17.3.1.1. India

            17.3.1.2. Indonesia

            17.3.1.3. Thailand

            17.3.1.4. Malaysia

            17.3.1.5. Rest of South Asia

        17.3.2. By Product Type

        17.3.3. By Application

        17.3.4. By End User 

    17.4. Market Attractiveness Analysis

    17.5. Key Market Participants - Intensity Mapping

    17.6. Drivers and Restraints - Impact Analysis

18. Oceania Digital Pathology Market Analysis 2016-2020 and Forecast 2021-2031

    18.1. Introduction

    18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2020

    18.3. Current and Future Market Size (US$ Mn) Trend Analysis and Forecast By Market Taxonomy, 2021-2031

        18.3.1.  By Country

            18.3.1.1. Australia

            18.3.1.2. New Zealand

        18.3.2. By Product Type

        18.3.3. By Application

        18.3.4. By End User 

    18.4. Market Attractiveness Analysis

    18.5. Key Market Participants - Intensity Mapping

    18.6. Drivers and Restraints - Impact Analysis

19. Middle East and Africa Digital Pathology Market Analysis 2016-2020 and Forecast 2021-2031

    19.1. Introduction

    19.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2020

    19.3. Current and Future Market Size (US$ Mn) Trend Analysis and Forecast By Market Taxonomy, 2021-2031

        19.3.1.  By Country

            19.3.1.1. South Africa

            19.3.1.2. GCC Countries

            19.3.1.3. Rest of Middle East and Africa

        19.3.2. By Product Type

        19.3.3. By Application

        19.3.4. By End User 

    19.4. Market Attractiveness Analysis

    19.5. Key Market Participants - Intensity Mapping

    19.6. Drivers and Restraints - Impact Analysis

20. Key and Emerging Countries Digital Pathology Market Analysis 2021 & 2031

    20.1. Introduction

        20.1.1. Market Value Proportion Analysis, By Key Countries

        20.1.2. Global Vs. Country Growth Comparison

    20.2. U.S. Digital Pathology Market Value (US$) Analysis, 2021 & 2031

        20.2.1. By Product Type

        20.2.2. By Application

        20.2.3. By End User 

    20.3. Canada Digital Pathology Market Value (US$) Analysis, 2021 & 2031

        20.3.1. By Product Type

        20.3.2. By Application

        20.3.3. By End User 

    20.4. Brazil Digital Pathology Market Value (US$) Analysis, 2021 & 2031

        20.4.1. By Product Type

        20.4.2. By Application

        20.4.3. By End User 

    20.5. Mexico Digital Pathology Market Value (US$) Analysis, 2021 & 2031

        20.5.1. By Product Type

        20.5.2. By Application

        20.5.3. By End Users

    20.6. Argentina Digital Pathology Market Value (US$) Analysis, 2021 & 2031

        20.6.1. By Product Type

        20.6.2. By Application

        20.6.3. By End User 

    20.7. U.K. Digital Pathology Market Value (US$) Analysis, 2021 & 2031

        20.7.1. By Product Type

        20.7.2. By Application

        20.7.3. By End User 

    20.8. Germany Digital Pathology Market Value (US$) Analysis, 2021 & 2031

        20.8.1. By Product Type

        20.8.2. By Application

        20.8.3. By End User 

    20.9. France Digital Pathology Market Value (US$) Analysis, 2021 & 2031

        20.9.1. By Product Type

        20.9.2. By Application

        20.9.3. By End User 

    20.10. Italy Digital Pathology Market Value (US$) Analysis, 2021 & 2031

        20.10.1. By Product Type

        20.10.2. By Application

        20.10.3. By End User 

    20.11. Spain Digital Pathology Market Value (US$) Analysis, 2021 & 2031

        20.11.1. By Product Type

        20.11.2. By Application

        20.11.3. By End User  

    20.12. Russia Digital Pathology Market Value (US$) Analysis, 2021 & 2031

        20.12.1. By Product Type

        20.12.2. By Application

        20.12.3. By End User 

    20.13. China Digital Pathology Market Value (US$) Analysis, 2021 & 2031

        20.13.1. By Product Type

        20.13.2. By Application

        20.13.3. By End User 

    20.14. Japan Digital Pathology Market Value (US$) Analysis, 2021 & 2031

        20.14.1. By Product Type

        20.14.2. By Application

        20.14.3. By End User 

    20.15. South Korea Digital Pathology Market Value (US$) Analysis, 2021 & 2031

        20.15.1. By Product Type

        20.15.2. By Application

        20.15.3. By End User 

    20.16. India Digital Pathology Market Value (US$) Analysis, 2021 & 2031

        20.16.1. By Product Type

        20.16.2. By Application

        20.16.3. By End User 

    20.17. Indonesia Digital Pathology Market Value (US$) Analysis, 2021 & 2031

        20.17.1. By Product Type

        20.17.2. By Application

        20.17.3. By End User 

    20.18. Thailand Digital Pathology Market Value (US$) Analysis, 2021 & 2031

        20.18.1. By Product Type

        20.18.2. By Application

        20.18.3. By End User

    20.19. Malaysia Digital Pathology Market Value (US$) Analysis, 2021 & 2031

        20.19.1. By Product Type

        20.19.2. By Application

        20.19.3. By End User

    20.20. Australia Digital Pathology Market Value (US$) Analysis, 2021 & 2031

        20.20.1. By Product Type

        20.20.2. By Application

        20.20.3. By End User 

    20.21. New Zealand Digital Pathology Market Value (US$) Analysis, 2021 & 2031

        20.21.1. By Product Type

        20.21.2. By Application

        20.21.3. By End User 

    20.22. GCC Countries Digital Pathology Market Value (US$) Analysis, 2021 & 2031

        20.22.1. By Product Type

        20.22.2. By Application

        20.22.3. By End User   

    20.23. South Africa Digital Pathology Market Value (US$) Analysis, 2021 & 2031

        20.23.1. By Product Type

        20.23.2. By Application

        20.23.3. By Modality

        20.23.4. By End User 

21. Market Structure Analysis

    21.1. Market Analysis by Tier of Companies

    21.2. Market Share Analysis of Top Players

    21.3. Market Concentration

    21.4. Market Presence Analysis

        21.4.1. By Regional footprint of Players

        21.4.2. Services foot print by Players

        21.4.3. Channel Foot Print by Players

22. Competition Analysis

    22.1. Competition Dashboard

    22.2. Competition Benchmarking

    22.3. Competition Deep Dive

        22.3.1. Danaher Corporation

            22.3.1.1. Overview

            22.3.1.2. Services Portfolio

            22.3.1.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.1.4. Sales Footprint

            22.3.1.5. Strategy Overview

                22.3.1.5.1. Marketing Strategy

                22.3.1.5.2. Services Strategy

                22.3.1.5.3. Channel Strategy

        22.3.2. F. Hoffmann-La Roche AG

   22.3.1.1. Overview

            22.3.1.2. Services Portfolio

            22.3.1.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.1.4. Sales Footprint

            22.3.1.5. Strategy Overview

        22.3.3. Huron Technologies International, Inc.

   22.3.1.1. Overview

            22.3.1.2. Services Portfolio

            22.3.1.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.1.4. Sales Footprint

            22.3.1.5. Strategy Overview

        22.3.4. Koninklijke Philips N.V.

   22.3.1.1. Overview

            22.3.1.2. Services Portfolio

            22.3.1.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.1.4. Sales Footprint

            22.3.1.5. Strategy Overview

        22.3.5. Olympus Corporation

   22.3.1.1. Overview

            22.3.1.2. Services Portfolio

            22.3.1.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.1.4. Sales Footprint

            22.3.1.5. Strategy Overview

        22.3.6. Hamamatsu Photonics K.K.

   22.3.1.1. Overview

            22.3.1.2. Services Portfolio

            22.3.1.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.1.4. Sales Footprint

            22.3.1.5. Strategy Overview

        22.3.7. Carl Zeiss AG

   22.3.1.1. Overview

            22.3.1.2. Services Portfolio

            22.3.1.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.1.4. Sales Footprint

            22.3.1.5. Strategy Overview

        22.3.8. 3DHISTECH Ltd.

   22.3.1.1. Overview

            22.3.1.2. Services Portfolio

            22.3.1.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.1.4. Sales Footprint

            22.3.1.5. Strategy Overview

        22.3.9. Hologic Inc.

   22.3.1.1. Overview

            22.3.1.2. Services Portfolio

            22.3.1.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.1.4. Sales Footprint

            22.3.1.5. Strategy Overview

        22.3.10. PerkinElmer, Inc.

   22.3.1.1. Overview

            22.3.1.2. Services Portfolio

            22.3.1.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.1.4. Sales Footprint

            22.3.1.5. Strategy Overview

        22.3.11. Visiopharm

   22.3.1.1. Overview

            22.3.1.2. Services Portfolio

            22.3.1.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.1.4. Sales Footprint

            22.3.1.5. Strategy Overview

        22.3.12. OptraSCAN, Inc.

   22.3.1.1. Overview

            22.3.1.2. Services Portfolio

            22.3.1.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.1.4. Sales Footprint

            22.3.1.5. Strategy Overview

        22.3.13. Inspirata, Inc.

   22.3.1.1. Overview

            22.3.1.2. Services Portfolio

            22.3.1.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.1.4. Sales Footprint

            22.3.1.5. Strategy Overview

        22.3.14. Sectra AB

   22.3.1.1. Overview

            22.3.1.2. Services Portfolio

            22.3.1.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.1.4. Sales Footprint

            22.3.1.5. Strategy Overview

23. Assumptions and Acronyms Used

24. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global Digital Pathology Market Volume (Units) Analysis and Opportunity Assessment 2016-2020, By Equipment Type

Table 02: Global Digital Pathology Market Value (US$ Mn) Analysis and Opportunity Assessment 2016-2020, By Component Type

Table 03: Global Digital Pathology Market Value (US$ Mn) Analysis and Opportunity Assessment 2016-2020, By Component Type

Table 04: Global Digital Pathology Market Value (US$ Mn) Analysis and Opportunity Assessment 2016-2020, By Component Type

Table 05: Global Digital Pathology Market Value (US$ Mn) Analysis and Opportunity Assessment 2016-2020, By Application

Table 06: Global Digital Pathology Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016-2020, By End User

Table 07: Global Digital Pathology Market Value (US$ Mn) Analysis and Opportunity Assessment 2016-2020, By Country

Table 08: North America Digital Pathology Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 09: North America Digital Pathology Market Value (US$ Mn) Analysis and Opportunity Assessment 2016-2020, By Product Type

Table 10: North America Digital Pathology Market Value (US$ Mn) Analysis and Opportunity Assessment 2016-2020, By Component Type

Table 11: North America Digital Pathology Market Value (US$ Mn) Analysis and Opportunity Assessment 2016-2020, By Component Type

Table 12: North America Digital Pathology Market Volume (Units) Analysis and Opportunity Assessment 2016-2020, By Equipment Type

Table 13: North America Digital Pathology Market Value (US$ Mn) Analysis and Opportunity Assessment 2016-2020, By Application

Table 14: North America Digital Pathology Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016-2020, By End User

Table 15: Latin America Digital Pathology Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 16: Latin America Digital Pathology Market Value (US$ Mn) Analysis and Opportunity Assessment 2016-2020, By Component Type

Table 17: Latin America Digital Pathology Market Value (US$ Mn) Analysis and Opportunity Assessment 2016-2020, By Component Type

Table 18: Latin America Digital Pathology Market Value (US$ Mn) Analysis and Opportunity Assessment 2016-2020, By Component Type

Table 19: Latin America Digital Pathology Market Volume (Units) Analysis and Opportunity Assessment 2016-2020, By Equipment Type

Table 20: Latin America Digital Pathology Market Value (US$ Mn) Analysis and Opportunity Assessment 2016-2020, By Application

Table 21: Latin America Digital Pathology Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016-2020, By End User

Table 22: Europe Digital Pathology Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 23: Europe Digital Pathology Market Value (US$ Mn) Analysis and Opportunity Assessment 2016-2020, By Component Type

Table 24: Europe Digital Pathology Market Value (US$ Mn) Analysis and Opportunity Assessment 2016-2020, By Component Type

Table 25: Europe Digital Pathology Market Value (US$ Mn) Analysis and Opportunity Assessment 2016-2020, By Component Type

Table 26: Europe Digital Pathology Market Volume (Units) Analysis and Opportunity Assessment 2016-2020, By Equipment Type

Table 27: Europe Digital Pathology Market Value (US$ Mn) Analysis and Opportunity Assessment 2016-2020, By Application

Table 28: Europe Digital Pathology Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016-2020, By End User

Table 29: East Asia Digital Pathology Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 30: East Asia Digital Pathology Market Value (US$ Mn) Analysis and Opportunity Assessment 2016-2020, By Component Type

Table 31: East Asia Digital Pathology Market Value (US$ Mn) Analysis and Opportunity Assessment 2016-2020, By Component Type

Table 32: East Asia Digital Pathology Market Value (US$ Mn) Analysis and Opportunity Assessment 2016-2020, By Component Type

Table 33: East Asia Digital Pathology Market Volume (Units) Analysis and Opportunity Assessment 2016-2020, By Equipment Type

Table 34: East Asia Digital Pathology Market Value (US$ Mn) Analysis and Opportunity Assessment 2016-2020, By Application

Table 35: East Asia Digital Pathology Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016-2020, By End User

Table 36: South Asia Digital Pathology Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 37: South Asia Digital Pathology Market Value (US$ Mn) Analysis and Opportunity Assessment 2016-2020, By Component Type

Table 38: South Asia Digital Pathology Market Value (US$ Mn) Analysis and Opportunity Assessment 2016-2020, By Component Type

Table 39: South Asia Digital Pathology Market Value (US$ Mn) Analysis and Opportunity Assessment 2016-2020, By Component Type

Table 40: South Asia Digital Pathology Market Volume (Units) Analysis and Opportunity Assessment 2016-2020, By Equipment Type

Table 41: South Asia Digital Pathology Market Value (US$ Mn) Analysis and Opportunity Assessment 2016-2020, By Application

Table 42: South Asia Digital Pathology Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016-2020, By End User

Table 43: Oceania Digital Pathology Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 44: Oceania Digital Pathology Market Value (US$ Mn) Analysis and Opportunity Assessment 2016-2020, By Component Type

Table 45: Oceania Digital Pathology Market Value (US$ Mn) Analysis and Opportunity Assessment 2016-2020, By Component Type

Table 46: Oceania Digital Pathology Market Value (US$ Mn) Analysis and Opportunity Assessment 2016-2020, By Component Type

Table 47: Oceania Digital Pathology Market Volume (Units) Analysis and Opportunity Assessment 2016-2020, By Equipment Type

Table 48: Oceania Digital Pathology Market Value (US$ Mn) Analysis and Opportunity Assessment 2016-2020, By Application

Table 49: Oceania Digital Pathology Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016-2020, By End User

Table 50: MEA Digital Pathology Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 51: MEA Digital Pathology Market Value (US$ Mn) Analysis and Opportunity Assessment 2016-2020, By Component Type

Table 52: MEA Digital Pathology Market Value (US$ Mn) Analysis and Opportunity Assessment 2016-2020, By Component Type

Table 53: MEA Digital Pathology Market Value (US$ Mn) Analysis and Opportunity Assessment 2016-2020, By Component Type

Table 54: MEA Digital Pathology Market Volume (Units) Analysis and Opportunity Assessment 2016-2020, By Equipment Type

Table 55: MEA Digital Pathology Market Value (US$ Mn) Analysis and Opportunity Assessment 2016-2020, By Application

Table 56: MEA Digital Pathology Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016-2020, By End User

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Global Digital Pathology Market Volume (Units) Analysis 2021- 2031 and Forecast2021-2031, By Equipment Type

Figure 02: Global Digital Pathology Market, Volume Share Analysis (%), By Equipment Type, 2021E

Figure 03: Brightfield Slide Scanners, Average Selling Price, Per Unit (US$),2021 and 2031

Figure 04: Fluorescence Slide Scanners, Average Selling Price, Per Unit (US$),2021 and 2031

Figure 05: Combination Slide Scanners, Average Selling Price, Per Unit (US$),2021 and 2031

Figure 06: Clinical Microscope, Average Selling Price, Per Unit (US$),2021 and 2031

Figure 07: Tissue Microarrays, Average Selling Price, Per Unit (US$),2021 and 2031

Figure 08: Global Digital Pathology Market Value Analysis (US$ Mn), 2021- 2031

Figure 09: Global Digital Pathology Market Value Forecast (US$ Mn),2021-2031

Figure 10: Global Digital Pathology Market Absolute $ Opportunity, 2021- 2029

Figure 11: Global Digital Pathology Market Share Analysis (%), By Component Type, 2021 & 2031

Figure 12: Global Digital Pathology Market Y-o-Y Analysis (%), By Component Type,2021-2031

Figure 13: Global Digital Pathology Market Attractiveness Analysis by Component Type,2021-2031

Figure 14: Global Digital Pathology Market Share Analysis (%), By Application, 2021 & 2031

Figure 15: Global Digital Pathology Market Y-o-Y Analysis (%), By Application,2021-2031

Figure 16: Global Digital Pathology Market Attractiveness Analysis by Application,2021-2031

Figure 17: Global Digital Pathology Market Share Analysis (%), By End User, 2021 & 2031

Figure 18: Global Digital Pathology Market Y-o-Y Analysis (%), By End User,2021-2031

Figure 19: Global Digital Pathology Market Attractiveness Analysis by End User,2021-2031

Figure 20: Global Digital Pathology Market Share Analysis (%), By Region, 2021 & 2031

Figure 21: Global Digital Pathology Market Y-o-Y Analysis (%), By Country,2021-2031

Figure 22: Global Digital Pathology Market Attractiveness Analysis by Region,2021-2031

Figure 23: North America Digital Pathology Market Value Share, By Component Type, 2021(E)

Figure 24: North America Digital Pathology Market Value Share, By Application, 2021(E)

Figure 25: North America Digital Pathology Market Value Share, By End User, 2021(E)

Figure 26: North America Digital Pathology Market Value Share, By Country, 2021(E)

Figure 27: North America Digital Pathology Market Value Analysis (US$ Mn), 2021- 2031

Figure 28: North America Digital Pathology Market Value Forecast (US$ Mn),2021-2031

Figure 29: North America Digital Pathology Market Attractiveness Analysis by Component Type,2021-2031

Figure 30: North America Digital Pathology Market Attractiveness Analysis by Application,2021-2031

Figure 31: North America Digital Pathology Market Attractiveness Analysis by End User,2021-2031

Figure 32: North America Digital Pathology Market Attractiveness Analysis by Country,2021-2031

Figure 33: Latin America Digital Pathology Market Value Share, By Component Type, 2021(E)

Figure 34: Latin America Digital Pathology Market Value Share, By Application, 2021(E)

Figure 35: Latin America Digital Pathology Market Value Share, By End User, 2021(E)

Figure 36: Latin America Digital Pathology Market Value Share, By Country, 2021(E)

Figure 37: Latin America Digital Pathology Market Value Analysis (US$ Mn), 2021- 2031

Figure 38: Latin America Digital Pathology Market Value Forecast (US$ Mn),2021-2031

Figure 39: South Asia Digital Pathology Market Value Analysis (US$ Mn), 2021- 2031

Figure 40: Latin America Digital Pathology Market Attractiveness Analysis by Component Type,2021-2031

Figure 41: South Asia Digital Pathology Market Value Forecast (US$ Mn),2021-2031

Figure 42: Latin America Digital Pathology Market Attractiveness Analysis by Application,2021-2031

Figure 43: Latin America Digital Pathology Market Attractiveness Analysis by End User,2021-2031

Figure 44: Latin America Digital Pathology Market Attractiveness Analysis by Country,2021-2031

Figure 45: Europe Digital Pathology Market Value Share, By Component Type, 2021(E)

Figure 46: Europe Digital Pathology Market Value Share, By Application, 2021(E)

Figure 47: Europe Digital Pathology Market Value Share, By End User, 2021(E)

Figure 48: Europe Digital Pathology Market Value Share, By Country, 2021(E)

Figure 49: Europe Digital Pathology Market Value Analysis (US$ Mn), 2021- 2031

Figure 50: Europe Digital Pathology Market Value Forecast (US$ Mn),2021-2031

Figure 51: Europe Digital Pathology Market Attractiveness Analysis by Component Type,2021-2031

Figure 52: Europe Digital Pathology Market Attractiveness Analysis by Application,2021-2031

Figure 53: Europe Digital Pathology Market Attractiveness Analysis by End User,2021-2031

Figure 54: Europe Digital Pathology Market Attractiveness Analysis by Country,2021-2031

Figure 55: East Asia Digital Pathology Market Value Share, By Component Type, 2021(E)

Figure 56: East Asia Digital Pathology Market Value Share, By Application, 2021(E)

Figure 57: East Asia Digital Pathology Market Value Share, By End User, 2021(E)

Figure 58: East Asia Digital Pathology Market Value Share, By Country 2021(E)

Figure 59: East Asia Digital Pathology Market Value Analysis (US$ Mn), 2021- 2031

Figure 60: East Asia Digital Pathology Market Value Forecast (US$ Mn),2021-2031

Figure 61: East Asia Digital Pathology Market Attractiveness Analysis by Component Type,2021-2031

Figure 62: East Asia Digital Pathology Market Attractiveness Analysis by Application,2021-2031

Figure 63: East Asia Digital Pathology Market Attractiveness Analysis by End User,2021-2031

Figure 64: East Asia Digital Pathology Market Attractiveness Analysis by Country,2021-2031

Figure 65: South Asia Digital Pathology Market Value Share, By Component Type, 2021(E)

Figure 66: South Asia Digital Pathology Market Value Share, By Application, 2021(E)

Figure 67: South Asia Digital Pathology Market Value Share, By End User, 2021(E)

Figure 68: South Asia Digital Pathology Market Value Share, By Country, 2021(E)

Figure 69: South Asia Digital Pathology Market Attractiveness Analysis by Component Type,2021-2031

Figure 70: South Asia Digital Pathology Market Attractiveness Analysis by Application,2021-2031

Figure 71: South Asia Digital Pathology Market Attractiveness Analysis by End User,2021-2031

Figure 72: South Asia Digital Pathology Market Attractiveness Analysis by Country,2021-2031

Figure 73: Oceania Digital Pathology Market Value Share, By Component Type, 2021(E)

Figure 74: Oceania Digital Pathology Market Value Share, By Application, 2021(E)

Figure 75: Oceania Digital Pathology Market Value Share, By End User, 2021(E)

Figure 76: Oceania Digital Pathology Market Value Share, Country, 2021(E)

Figure 77: Oceania Digital Pathology Market Value Analysis (US$ Mn), 2021- 2031

Figure 78: Oceania Digital Pathology Market Value Forecast (US$ Mn),2021-2031

Figure 79: Oceania Digital Pathology Market Attractiveness Analysis by Component Type,2021-2031

Figure 80: Oceania Digital Pathology Market Attractiveness Analysis by Application,2021-2031

Figure 81: Oceania Digital Pathology Market Attractiveness Analysis by End User,2021-2031

Figure 82: Oceania Digital Pathology Market Attractiveness Analysis by Country,2021-2031

Figure 83: MEA Digital Pathology Market Value Share, By Component Type, 2021(E)

Figure 84: MEA Digital Pathology Market Value Share, By Application, 2021(E)

Figure 85: MEA Digital Pathology Market Value Share, By End User, 2021(E)

Figure 86: MEA Digital Pathology Market Value Share, By Component Type, 2021(E)

Figure 87: MEA Digital Pathology Market Value Analysis (US$ Mn), 2021- 2031

Figure 88: MEA Digital Pathology Market Value Forecast (US$ Mn),2021-2031

Figure 89: MEA Digital Pathology Market Attractiveness Analysis by Component Type,2021-2031

Figure 90: MEA Digital Pathology Market Attractiveness Analysis by Application,2021-2031

Figure 91: MEA Digital Pathology Market Attractiveness Analysis by End User,2021-2031

Figure 92: MEA Digital Pathology Market Attractiveness Analysis by Country,2021-2031

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Anatomic Pathology Market

Published : August 2020

Healthcare

Cellular Pathology Market

Published : June 2018

Healthcare

Quantitative Pathology Imaging Market

Published : September 2017

Healthcare

Pathology Devices Market

Published : January 2016

Google translate

Digital Pathology Market